Immunotherapy in translational cancer research / edited by Laurence J.N. Cooper, Elizabeth A. Mittendorf, Judy Moyes, Sabitha Prabhakaran.

"Immunotherapy in Translational Cancer Research is a volume in Translational Oncology, an exciting book series that focuses on translational cancer research. Immunotherapy has become a key aspect in the treatment of a wide variety of cancers, and this book is specifically designed for physician...

Full description

Saved in:
Bibliographic Details
Other Authors: Cooper, Laurence J. N. (Editor), Mittendorf, Elizabeth A. (Editor), Moyes, Judy, 1953- (Editor), Prabhakaran, Sabitha (Editor)
Format: eBook
Language:English
Published: Hoboken, NJ : John Wiley & Sons, Inc., 2018.
Series:Translational oncology (Series)
Subjects:
Online Access:Click for online access

MARC

LEADER 00000cam a2200000 i 4500
001 on1014000386
003 OCoLC
005 20240809213013.0
006 m o d
007 cr cnu---unuuu
008 171129t20182018nju ob 001 0 eng
010 |a  2017057426 
040 |a DLC  |b eng  |e rda  |e pn  |c DLC  |d OCLCO  |d OCLCA  |d N$T  |d EBLCP  |d N$T  |d DG1  |d OCLCF  |d MERER  |d OCLCO  |d OCLCQ  |d UAB  |d OCLCO  |d OCLCQ  |d UPM  |d OCLCO  |d YDX  |d OCLCQ  |d STF  |d COO  |d OCLCQ  |d CHVBK  |d OCLCQ  |d CASUM  |d AU@  |d OCLCO  |d WYU  |d OCLCO  |d OCLCA  |d U3W  |d OCLCO  |d OCLCA  |d OCLCQ  |d YDX  |d OCLCO  |d OCLCQ  |d UKAHL  |d OCLCQ  |d SFB  |d OCLCQ  |d OCLCA  |d OCLCQ  |d UX1  |d K6U  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCA 
019 |a 1023526120  |a 1050744060  |a 1100433620  |a 1175623107 
020 |a 9781118684504  |q (electronic book) 
020 |a 1118684508  |q (electronic book) 
020 |a 9781118684535  |q (electronic book) 
020 |a 1118684532  |q (electronic book) 
020 |z 9781118684528 
020 |z 1118684524 
020 |z 9781118123225  |q (hardcover) 
020 |z 1118123220 
035 |a (OCoLC)1014000386  |z (OCoLC)1023526120  |z (OCoLC)1050744060  |z (OCoLC)1100433620  |z (OCoLC)1175623107 
042 |a pcc 
050 1 4 |a RC271.I45  |b I46 2018 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
049 |a HCDD 
245 0 0 |a Immunotherapy in translational cancer research /  |c edited by Laurence J.N. Cooper, Elizabeth A. Mittendorf, Judy Moyes, Sabitha Prabhakaran. 
264 1 |a Hoboken, NJ :  |b John Wiley & Sons, Inc.,  |c 2018. 
264 4 |c ©2018 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Translational oncology 
504 |a Includes bibliographical references and index. 
520 |a "Immunotherapy in Translational Cancer Research is a volume in Translational Oncology, an exciting book series that focuses on translational cancer research. Immunotherapy has become a key aspect in the treatment of a wide variety of cancers, and this book is specifically designed for physicians, clinical fellows, medical students, graduate students, scientists, pharmaceutical executives, public health and public policy government leaders and community oncologists. Each chapter is consistently organized and features three essential themes: Development of the immunotherapy; Hurdles that were overcome to scale up and undertake clinical trials; and Clinical experience and application of research. Concepts, examples and alternative strategies to achieve individualized targeted therapy are presented, with thorough consideration of the relevant history, current state and future directions of emerging cancer-fighting therapies, drug development, clinical trials, and governmental resources and regulatory issues."--Provided by publisher. 
588 0 |a Online resource; title from digital title page (viewed on March 11, 2019). 
505 0 |a Translation in immunology: the role of translational biomarkers to guide clinical use of immunotherapy for cancer -- Monoclonal antibody therapy -- Somatic mutations and immunotherapy -- Checkpoint blockade -- Myeloid leukemia vaccines -- Cancer vaccines for solid tumors -- Immunotherapy with non-genetically modified T cells -- Immunotherapy with genetically modified T cells -- Immunomodulation with adjuvants and cytokines -- Immune cell migration in cancer and immunotherapy -- Repurposing of drugs for immunotherapy -- Immunomodulation with radiation -- Good manufacturing practices facilities for cellular therapy -- T cell receptor mimic anitbodies -- Stem cell transplantation for treatment of malignancy -- Natural killer cell-based immunotherapy -- Immunologic monitoring in immuno-oncology -- Cell-based therapies for canine cancer -- Interaction between targeted therapy and immunotherapy. 
650 0 |a Cancer  |x Immunotherapy. 
650 0 |a Immunotherapy. 
650 0 |a Cancer  |x Immunological aspects. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Cancer  |x Immunological aspects  |2 fast 
650 7 |a Cancer  |x Immunotherapy  |2 fast 
650 7 |a Immunotherapy  |2 fast 
700 1 |a Cooper, Laurence J. N.,  |e editor. 
700 1 |a Mittendorf, Elizabeth A.,  |e editor. 
700 1 |a Moyes, Judy,  |d 1953-  |e editor. 
700 1 |a Prabhakaran, Sabitha,  |e editor. 
776 0 8 |i Print version:  |t Immunotherapy in translational cancer research.  |d Hoboken, NJ : Wiley, 2018  |z 9781118123225  |w (DLC) 2017056123 
830 0 |a Translational oncology (Series) 
856 4 0 |u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=5287418  |y Click for online access 
903 |a EBC-AC 
994 |a 92  |b HCD